Skip to main content

GILD

GILEAD SCIENCES, INC.
ShareXLinkedInReddit
Sector
Health Care
Industry
Biotechnology
Last price
$129.83
As of

Active signals for GILD

  • mediumEARNINGS_BEAT

    Q3-2025: Beat consensus by 13.7% — EPS $2.47 vs $2.1728 estimate

  • mediumEARNINGS_BEAT

    Q3-2025: Beat consensus by 13.7% — EPS $2.47 vs $2.1728 estimate

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — GILEAD Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — GILEAD Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infec

  • mediumEARNINGS_BEAT

    Q3-2025: Beat consensus by 13.7% — EPS $2.47 vs $2.1728 estimate

Top institutional holders of GILD (13F)

FundMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLC$606.4M0.80%,
RENAISSANCE TECHNOLOGIES LLC$342.3M0.53%-49.0%
RENAISSANCE TECHNOLOGIES LLC$300M0.47%-22.8%
CITADEL ADVISORS LLC$136.6M0.02%,
CITADEL ADVISORS LLC$127.6M0.02%-15.5%
MILLENNIUM MANAGEMENT LLC$87.1M0.04%+41.3%
MILLENNIUM MANAGEMENT LLC$54.3M0.02%+8.4%
MILLENNIUM MANAGEMENT LLC$45.3M0.02%,
D. E. Shaw & Co., Inc.$45.1M0.03%,
Bridgewater Associates, LP$42.8M0.17%,
Bridgewater Associates, LP$35.9M0.13%-24.1%
Bridgewater Associates, LP$25.2M0.11%-38.2%
D. E. Shaw & Co., Inc.$9.9M0.01%-80.1%
D. E. Shaw & Co., Inc.$2.8M0.00%-75.2%
Point72 Asset Management, L.P.$2.1M0.00%,
Point72 Asset Management, L.P.$1.7M0.00%-26.2%
TWO SIGMA INVESTMENTS, LP$836K0.00%+0.0%
TWO SIGMA INVESTMENTS, LP$736K0.00%,

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, GILD

Related tickers

See more GILD signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track GILD in your watchlist and get notified the moment a new signal fires.

Track GILD on Kresmion →